• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂解作用对不同核/壳药物位置的自微乳化药物递送系统(SMEDDS)药物释放的影响。

Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.

作者信息

Zhang Jianbin, Lv Yan, Zhao Shan, Wang Bing, Tan Mingqian, Xie Hongguo, Lv Guojun, Ma Xiaojun

机构信息

Laboratory of Biomedical Material Engineering, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.

出版信息

AAPS PharmSciTech. 2014 Jun;15(3):731-40. doi: 10.1208/s12249-014-0096-9. Epub 2014 Feb 20.

DOI:10.1208/s12249-014-0096-9
PMID:24554238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4037486/
Abstract

The objective of this study is to investigate the effect of lipolysis on the release of poorly water-soluble drug from SMEDDS in the perspective of drug core/shell location. For this purpose, four SMEDDS formulations with various core/shell properties were developed based on long-chain lipid or medium-chain lipid as well as different surfactant/oil ratios. Poorly water-soluble drugs, hymecromone and resveratrol, were significantly solubilized in all SMEDDS formulations and the diluted microemulsions. Fluorescence spectra analysis indicated that hymecromone was mainly located in the shell of microemulsions, while resveratrol was located in the core. The effect of lipolysis on the release rates of drugs with different core/shell locations were investigated by a modified in vitro drug release model. For the drug located in the shell, hymecromone, the release profiles were not affected during the lipolysis process and no significant differences were observed among four formulations. For the drug located in the core, resveratrol, the release rates were increased to various degrees depending on the extent of digestion. In conclusion, the drug core/shell location plays an important role for determining the effect of lipolysis on drug release from SMEDDS formulation.

摘要

本研究的目的是从药物核/壳位置的角度研究脂解作用对自自微乳药物传递系统(SMEDDS)中难溶性药物释放的影响。为此,基于长链脂质或中链脂质以及不同的表面活性剂/油比例,开发了四种具有不同核/壳性质的SMEDDS制剂。难溶性药物羟甲香豆素和白藜芦醇在所有SMEDDS制剂和稀释的微乳剂中均有显著增溶。荧光光谱分析表明,羟甲香豆素主要位于微乳剂的壳层,而白藜芦醇位于核层。通过改进的体外药物释放模型研究了脂解作用对不同核/壳位置药物释放速率的影响。对于位于壳层的药物羟甲香豆素,在脂解过程中释放曲线不受影响,四种制剂之间未观察到显著差异。对于位于核层的药物白藜芦醇,释放速率根据消化程度不同程度增加。总之,药物核/壳位置在确定脂解作用对SMEDDS制剂中药物释放的影响方面起着重要作用。

相似文献

1
Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.脂解作用对不同核/壳药物位置的自微乳化药物递送系统(SMEDDS)药物释放的影响。
AAPS PharmSciTech. 2014 Jun;15(3):731-40. doi: 10.1208/s12249-014-0096-9. Epub 2014 Feb 20.
2
A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism.一种用于克服肠道白藜芦醇毒性和首过代谢的自微乳化药物递送系统。
J Pharm Sci. 2014 Nov;103(11):3491-3500. doi: 10.1002/jps.24114. Epub 2014 Aug 7.
3
Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.混合脂质相 SMEDDS 作为一种提高白藜芦醇溶解度的创新方法。
Drug Dev Ind Pharm. 2014 Jan;40(1):102-9. doi: 10.3109/03639045.2012.749888. Epub 2013 Jan 10.
4
Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.直接压片法制备的自微乳片剂提高了白藜芦醇的递送效果。
Int J Pharm. 2018 Sep 5;548(1):263-275. doi: 10.1016/j.ijpharm.2018.06.065. Epub 2018 Jun 30.
5
Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems.固化对脂质基胶体载体性能的影响:油基体系与自乳化体系
Curr Drug Deliv. 2015;12(1):16-25. doi: 10.2174/1567201811666140716122644.
6
Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.设计用于口服给药的脂基制剂:对消化的影响
AAPS PharmSciTech. 2012 Jun;13(2):637-46. doi: 10.1208/s12249-012-9787-2. Epub 2012 May 1.
7
Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals.自微乳药物传递系统的开发用于口服递送难溶性营养药物。
Drug Dev Ind Pharm. 2018 Jun;44(6):895-901. doi: 10.1080/03639045.2017.1419365. Epub 2017 Dec 26.
8
Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.固体自乳化药物传递系统消化过程中难溶性药物的增溶行为。
Eur J Pharm Biopharm. 2018 Sep;130:236-246. doi: 10.1016/j.ejpb.2018.07.006. Epub 2018 Jul 4.
9
Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design.使用亲水性载体的阿托伐他汀固体自微乳化:一种设计
Drug Dev Ind Pharm. 2015;41(7):1213-22. doi: 10.3109/03639045.2014.938655. Epub 2014 Jul 14.
10
Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System Containing Atorvastatin Calcium.阿托伐他汀钙自微乳给药系统的制剂及体外评价。
Curr Drug Deliv. 2019;16(8):768-779. doi: 10.2174/1567201816666190820143957.

引用本文的文献

1
Self-Emulsifying Drug Delivery System Enhances Tissue Distribution of Cinnamaldehyde by Altering the Properties of the Mucus Layer.自乳化药物传递系统通过改变黏液层的性质来增强肉桂醛的组织分布。
AAPS PharmSciTech. 2022 Sep 21;23(7):261. doi: 10.1208/s12249-022-02416-4.
2
Supersaturation and Solubilization upon In Vitro Digestion of Fenofibrate Type I Lipid Formulations: Effect of Droplet Size, Surfactant Concentration and Lipid Type.非诺贝特 I 型脂质制剂体外消化时的过饱和与增溶作用:液滴大小、表面活性剂浓度和脂质类型的影响
Pharmaceutics. 2021 Aug 18;13(8):1287. doi: 10.3390/pharmaceutics13081287.
3
Enhanced Bioavailability of AC1497, a Novel Anticancer Drug Candidate, via a Self-Nanoemulsifying Drug Delivery System.通过自纳米乳化药物递送系统提高新型抗癌候选药物AC1497的生物利用度。
Pharmaceutics. 2021 Jul 27;13(8):1142. doi: 10.3390/pharmaceutics13081142.
4
Improved bioaccessibility of polymethoxyflavones loaded into high internal phase emulsions stabilized by biopolymeric complexes: A dynamic digestion study via TNO's gastrointestinal model.负载于生物聚合物复合物稳定的高内相乳液中的聚甲氧基黄酮的生物可及性提高:通过荷兰应用科学研究院胃肠模型进行的动态消化研究
Curr Res Food Sci. 2019 Dec 16;2:11-19. doi: 10.1016/j.crfs.2019.11.007. eCollection 2020 Jun.
5
Preparation and in vitro performance evaluation of resveratrol for oral self-microemulsion.白藜芦醇口服自微乳制剂的制备及体外评价。
PLoS One. 2019 Apr 16;14(4):e0214544. doi: 10.1371/journal.pone.0214544. eCollection 2019.
6
monitoring of the structural change of microemulsions in simulated gastrointestinal conditions by SAXS and FRET.通过小角X射线散射(SAXS)和荧光共振能量转移(FRET)监测模拟胃肠道条件下微乳液的结构变化。
Acta Pharm Sin B. 2018 Jul;8(4):655-665. doi: 10.1016/j.apsb.2018.05.008. Epub 2018 May 23.
7
Biopharmaceutical insights of particulate emulsified systems - a prospective overview.微粒乳化系统的生物制药见解 - 前瞻性概述。
Lipids Health Dis. 2018 May 10;17(1):112. doi: 10.1186/s12944-018-0757-x.

本文引用的文献

1
Administration of resveratrol: What formulation solutions to bioavailability limitations?白藜芦醇的给药途径:如何解决生物利用度限制的问题?
J Control Release. 2012 Mar 10;158(2):182-93. doi: 10.1016/j.jconrel.2011.09.083. Epub 2011 Sep 25.
2
Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering.利用同步加速器小角 X 射线散射研究制剂脂质消化过程中液晶纳米结构的实时演变。
Langmuir. 2011 Aug 2;27(15):9528-34. doi: 10.1021/la2011937. Epub 2011 Jun 29.
3
In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems.体外脂肪分解模型作为一种工具,用于表征口服脂质和表面活性剂为基础的药物传递系统。
Int J Pharm. 2011 Sep 30;417(1-2):245-55. doi: 10.1016/j.ijpharm.2011.03.002. Epub 2011 Mar 15.
4
Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.自微乳药物传递系统递送的非诺贝特溶出特性。
J Pharm Pharmacol. 2010 Dec;62(12):1685-96. doi: 10.1111/j.2042-7158.2010.01182.x. Epub 2010 Oct 5.
5
Structured emulsion-based delivery systems: controlling the digestion and release of lipophilic food components.基于结构乳液的递送系统:控制亲脂性食物成分的消化和释放。
Adv Colloid Interface Sci. 2010 Sep 15;159(2):213-28. doi: 10.1016/j.cis.2010.06.010. Epub 2010 Jul 3.
6
Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes.非离子表面活性剂对体外甘油三酯消化的影响及其对胰酶消化的敏感性。
Eur J Pharm Sci. 2010 Oct 9;41(2):376-82. doi: 10.1016/j.ejps.2010.07.005. Epub 2010 Jul 13.
7
Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system.自微乳化药物传递系统提高大豆苷元的口服生物利用度
Chem Pharm Bull (Tokyo). 2010 May;58(5):639-43. doi: 10.1248/cpb.58.639.
8
Microemulsion formulations for the transdermal delivery of testosterone.用于睾酮经皮传递的微乳制剂。
Eur J Pharm Sci. 2010 Jun 14;40(3):188-96. doi: 10.1016/j.ejps.2010.03.008. Epub 2010 Mar 19.
9
Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.微乳作为药物传递系统,以提高难溶性药物的溶解度和生物利用度。
Expert Opin Drug Deliv. 2010 Apr;7(4):445-60. doi: 10.1517/17425241003596337.
10
Microemulsion system with improved loading of piroxicam: a study of microstructure.载药量提高的吡罗昔康微乳系统:微观结构研究。
AAPS PharmSciTech. 2009;10(4):1286-94. doi: 10.1208/s12249-009-9328-9. Epub 2009 Oct 30.